If the LOA had been better, it would have gone senior.....and most likely, many wouldn't be losing seats. The FDA positions would (and should) have come out of the top end of the seniority lists.

I was all for "fixing" the FDA's when we had the leverage that wasn't recognized by the union. Not now. They can only threaten to furlough and excess so much. Eventually they will run out of folks who can be pressured to go overseas. At that point, the company will have to induce folks to bid MD-11 HKG (for example) instead of pressure them. When that happens, the company will be negotiating against themselves.

68% of us voted for the LOA (not me), not once but a few times. Those that bid it, did so voluntarily....under economic duress perhaps, but still voluntarily. The best fix is to do nothing for the LOA. Eventually the company will have to do something on their own. In the meantime, the consequences of the poor LOA will have to be weathered by us as they try to increase the sizes. In the long run, it will be best.

The way these FDA's were manned is a significant reason for the "re-alignment". All these years, the company had no problem with the seniority being "out of alignment", but suddenly had an issue with it now.
I have to chuckle when I think of all the folks who didn't care about the LOA because it "wouldn't affect them"....now having to be displaced.

For those that bid the LOA, I honestly wish you well, but I'm not willing to give up anything to better your lot.....I believe the FDA's have cost me enough already. You made your bed.......against the advice of others.....now go lie in it.